| 000 | 01745 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515154751.0 | ||
| 264 | 0 | _c20090601 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1365-2885 | ||
| 024 | 7 |
_a10.1111/j.1365-2885.2008.00999.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNagilla, R | |
| 245 | 0 | 0 |
_aEnantiomeric disposition of ketorolac in goats following administration of a single intravenous and oral dose. _h[electronic resource] |
| 260 |
_bJournal of veterinary pharmacology and therapeutics _cFeb 2009 |
||
| 300 |
_a49-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGoats _xblood |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aInfusions, Intravenous _xveterinary |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 |
_aKetorolac _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aStereoisomerism |
| 700 | 1 | _aDeshmukh, D D | |
| 700 | 1 | _aCopedge, K J | |
| 700 | 1 | _aMiller, S | |
| 700 | 1 | _aMartin, B | |
| 700 | 1 | _aBell, E C | |
| 700 | 1 | _aDuran, S H | |
| 700 | 1 | _aRavis, W R | |
| 773 | 0 |
_tJournal of veterinary pharmacology and therapeutics _gvol. 32 _gno. 1 _gp. 49-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2885.2008.00999.x _zAvailable from publisher's website |
| 999 |
_c18608239 _d18608239 |
||